An exploratory, open-label, investigator-initiated study of interleukin-17 blockade in patients with moderate-to-severe papulopustular rosacea.
A M KumarA S ChiouYi-Hsien ShihS LiAnne Lynn S ChangPublished in: The British journal of dermatology (2020)